# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

A. 510(k) Number: k152025   
B. Purpose for Submission: New Device   
C. Measurand: Methadone and Buprenorphine   
D. Type of Test: Qualitative immunochromatographic assay   
E. Applicant: Assure Tech. Co., Ltd.

# F. Proprietary and Established Names:

AssureTech Buprenorphine Strip   
AssureTech Methadone Strip   
AssureTech Buprenorphine/Methadone Panel Dip   
AssureTech Buprenorphine/Methadone Quick Cup   
AssureTech Buprenorphine/Methadone Turn Key-Split Cup

# G. Regulatory Information:

1. Regulation section:

21 CFR, 862.3620 Methadone Test System   
21 CFR 862.3650 Opiate test system

2. Classification:

Class II

3. Product code: DJR, DJG

4. Panel: 91, Toxicology

# H. Intended Use:

1. Intended use(s): See Indications for Use below.

2. Indication(s) for use:

AssureTech Buprenorphine Strip:

The AssureTech Buprenorphine Strip test is an immunochromatographic assay for the qualitative determination of Buprenorphine in human urine at a Cut-Off concentration of $1 0 \mathrm { n g / m L }$ . This test is calibrated to Buprenorphine (calibrator).

The test may yield preliminary positive results when prescription drug Buprenorphine is ingested, even at or above therapeutic doses. There are no uniformly recognized drug levels for Buprenorphine in urine. The test provides only preliminary test results. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatography/Mass Spectrometry is the preferred confirmatory method. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive.

For in vitro diagnostic use only. The test is intended for over-the-counter and for prescription use.

AssureTech Methadone Strip:

The AssureTech Methadone Strip test is an immunochromatographic assay for the qualitative determination of Methadone in human urine at a Cut-Off concentration of $3 0 0 \mathrm { n g / m L }$ . This test is calibrated to Methadone (calibrator).

The test provides only preliminary test results. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatography/Mass Spectrometry is the preferred confirmatory method. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive.

For in vitro diagnostic use only. The test is intended for over-the-counter and for prescription use.

AssureTech Buprenorphine/Methadone Panel Dip:

The AssureTech Buprenorphine/Methadone Panel Dip test is an immunochromatographic assay for the qualitative determination of Buprenorphine and Methadone in human urine at a Cut-Off concentration of $1 0 \mathrm { n g / m L }$ and 300 $\mathrm { n g / m L }$ , respectively. These tests are calibrated to Buprenorphine and Methadone (calibrators).

The test may yield preliminary positive results when prescription drug Buprenorphine is ingested, even at or above therapeutic doses. There are no uniformly recognized drug levels for Buprenorphine in urine. The test provides only preliminary test results. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatography/Mass Spectrometry is the preferred confirmatory method. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive.

For in vitro diagnostic use only. The tests are intended for over-the-counter and for prescription use.

AssureTech Buprenorphine/Methadone Quick Cup:

The AssureTech Buprenorphine/Methadone Quick Cup test is an immunochromatographic assay for the qualitative determination of Buprenorphine and Methadone in human urine at a Cut-Off concentration of $1 0 \mathrm { n g / m L }$ and 300 $\mathrm { n g / m L }$ , respectively. These tests are calibrated to Buprenorphine and Methadone (calibrators).

The test may yield preliminary positive results when prescription drug Buprenorphine is ingested, even at or above therapeutic doses. There are no uniformly recognized drug levels for Buprenorphine in urine. The test provides only preliminary test results. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatography/Mass Spectrometry is the preferred confirmatory method. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive.

For in vitro diagnostic use only. The tests are intended for over-the-counter and for prescription use.

AssureTech Buprenorphine/Methadone Turn Key-Split Cup:

The AssureTech Buprenorphine/Methadone Turn Key-Split Cup test is an immunochromatographic assay for the qualitative determination of Buprenorphine and Methadone in human urine at a Cut-Off concentration of $1 0 \mathrm { n g / m L }$ and 300

$\mathrm { n g / m L }$ , respectively. These tests are calibrated to Buprenorphine and Methadone (calibrators).

The test may yield preliminary positive results when prescription drug Buprenorphine is ingested, even at or above therapeutic doses. There are no uniformly recognized drug levels for Buprenorphine in urine. The test provides only preliminary test results. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatography/Mass Spectrometry is the preferred confirmatory method. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive.

For in vitro diagnostic use only. The tests are intended for over-the-counter and for prescription use.

3. Special conditions for use statement(s): For Prescription and Over-the-counter Use

4. Special instrument requirements: Not applicable; this is a visually read single use device.

# I. Device Description:

The AssureTech Buprenorphine Strip, AssureTech Methadone Strip, AssureTech Buprenorphine/Methadone Panel Dip, AssureTech Buprenorphine/Methadone Quick Cup and AssureTech Buprenorphine/Methadone Turn Key-Split Cup are immunochromatographic assays that use a lateral flow system for the qualitative detection of Buprenorphine and/or Methadone (target analytes) in human urine. The Quick Cup format does not contain a turn-key for device activation. The tests are the first step in a two-step process. The second step is to send the sample for laboratory testing if preliminary positive results are obtained.

# J. Substantial Equivalence Information:

1. Predicate device name(s): Chemtrue® BUP/TCA Single/Multi-Panel Drug Screen Dip Card/Cup/Cassette Tests Chemtrue® Multi-Panel Drug Screen Dip Card Tests Chemtrue® Multi-Panel Drug Screen Dip Card with OPI 2000 Tests

2. Predicate 510(k) number(s): k142396

3. Comparison with predicate:

<table><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Device</td><td rowspan=1 colspan=1>Predicate</td></tr><tr><td rowspan=1 colspan=1>Indication(s)for Use</td><td rowspan=1 colspan=1>For the qualitative determination of drugsof abuse in human urine.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Calibrator</td><td rowspan=1 colspan=1>Buprenorphine, Methadone</td><td rowspan=1 colspan=1>Amphetamine, Cocaine,Marijuana, Morphine,Methamphetamine,Phencyclidine,Benzodiazepines,Barbiturates, Ecstasy,Methadone, Oxycodoneand TricyclicAntidepressants</td></tr><tr><td rowspan=1 colspan=1>Methodology</td><td rowspan=1 colspan=1>Competitive binding, lateral flowimmunochromatographic assays basedon the principle of antigen antibodyimmunochemistry.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Type of Test</td><td rowspan=1 colspan=1>Qualitative</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Specimen</td><td rowspan=1 colspan=1>Human Urine</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Cut-OffValues</td><td rowspan=1 colspan=1>10 ng/mL (Buprenophrine) and300 ng/mL (Methadone)</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Intended Use</td><td rowspan=1 colspan=1>For over-the-counter andprescription useuses.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Configurations</td><td rowspan=1 colspan=1>Strip, Panel Dip, Cup with orwithout turn-key</td><td rowspan=1 colspan=1>Dip Card, Cup,Cassette Tests</td></tr></table>

K. Standard/Guidance Document Referenced (if applicable): None referenced

# L. Test Principle:

AssureTech Buprenorphine Strip, AssureTech Methadone Strip, AssureTech Buprenorphine/Methadone Panel Dip, AssureTech Buprenorphine/Methadone Quick Cup and AssureTech Buprenorphine/Methadone Turn Key-Split Cup are rapid tests for the

qualitative detection of Buprenorphine and/or Methadone in urine samples. The tests are lateral flow chromatographic immunoassays. During testing, a urine specimen migrates upward by capillary action. If target drugs present in the urine specimen are below the cut-off concentration, it will not saturate the binding sites of its specific monoclonal mouse antibody coated on the particles. The antibody-coated particles will then be captured by immobilized drug-conjugate and a visible colored line will show up in the test line region. The colored line will not form in the test line region if the target drug level exceeds its cutoff-concentration because it will saturate all the binding sites of the antibody coated on the particles. A band should form in the control region of the devices regardless of the presence of drug or metabolite in the sample to indicate that the tests have been performed properly.

# M. Performance Characteristics (if/when applicable):

1. Analytical performance:

a. Precision/Reproducibility:

Precision studies were carried out for samples with concentrations of - $100 \%$ , - $7 5 \%$ , $- 5 0 \%$ , $- 2 5 \%$ , cutoff, $+ 2 5 \%$ , $+ 5 0 \%$ , $+ 7 5 \%$ and $+ 1 0 0 \%$ cut off. These samples were prepared by spiking drug in negative urine samples. Each drug concentration was confirmed by GC/MS. These studies were conducted by 3 operators with 3 lots of each device in two runs per day for 25 days $( \mathrm { n } { = } 5 0 )$ . The results obtained are summarized in the following tables.

# Buprenorphine

AssureTech Buprenorphine Strip   

<table><tr><td rowspan=1 colspan=1>Lot#</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%cutoff</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>+25%cut off</td><td rowspan=1 colspan=1>+50%cut off</td><td rowspan=1 colspan=1>+75%cut off</td><td rowspan=1 colspan=1>+100%cut off</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>4-/46+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>1-/49+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>3-/47+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

AssureTech Buprenorphine /Methadone Panel Dip   

<table><tr><td rowspan=1 colspan=1>Lot#</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%cutoff</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>+25%cut off</td><td rowspan=1 colspan=1>+50%cut off</td><td rowspan=1 colspan=1>+75%cut off</td><td rowspan=1 colspan=1>+100%cut off</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>3-/47+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>2-/48+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>2-/48+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

AssureTech Buprenorphine/Methadone Turn-Key Split Cup   

<table><tr><td rowspan=1 colspan=1>Lot#</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%cutoff</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>+25%cut off</td><td rowspan=1 colspan=1>+50%cut off</td><td rowspan=1 colspan=1>+75%cut off</td><td rowspan=1 colspan=1>+100%cut off</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>4-/46+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>2-/48+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>2-/48+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

<table><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%cutoff</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>+25%cut off</td><td rowspan=1 colspan=1>+50%cut off</td><td rowspan=1 colspan=1>+75%cut off</td><td rowspan=1 colspan=1>+100%cut off</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>2-/48+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>2-/48+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>3-/47+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

# Methadone

AssureTech Methadone Strip   

<table><tr><td rowspan=1 colspan=1>Lot#</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%cutoff</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>+25%cut off</td><td rowspan=1 colspan=1>+50%cut off</td><td rowspan=1 colspan=1>+75%cut off</td><td rowspan=1 colspan=1>+100%cut off</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>2-/48+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>3-/47+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>4-46+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

AssureTech Buprenorphine/Methadone Panel Dip   

<table><tr><td rowspan=1 colspan=1>Lot#</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%cutoff</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>+25%cut off</td><td rowspan=1 colspan=1>+50%cut off</td><td rowspan=1 colspan=1>+75%cut off</td><td rowspan=1 colspan=1>+100%cut off</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>2-/48+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>3-/47+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>2-/48+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

AssureTech Buprenorphine/Methadone Turn-Key Split Cup   

<table><tr><td rowspan=1 colspan=1>Lot#</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%cutoff</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>+25%cut off</td><td rowspan=1 colspan=1>+50%cut off</td><td rowspan=1 colspan=1>+75%cut off</td><td rowspan=1 colspan=1>+100%cut off</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>1-/49+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>2-/48+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>3-/47+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

AssureTech Buprenorphine/Methadone Quick Cup   

<table><tr><td rowspan=1 colspan=1>Lot#</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%cutoff</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>+25%cut off</td><td rowspan=1 colspan=1>+50%cut off</td><td rowspan=1 colspan=1>+75%cut off</td><td rowspan=1 colspan=1>+100%cut off</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>3-/47+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>2-/48+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>2-/48+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

b. Linearity/assay reportable range:

Not applicable.

c. Traceability, Stability, Expected values (controls, calibrators, or methods):

External control materials are not supplied with the devices; however, the package inserts list information on how to obtain control materials.

Sample Storage and Stability:

Protocols and acceptance criteria for real time, accelerated and transportation simulation stability studies were described and found to be acceptable. The real time stability data supports the sponsor’s claim that the devices are stable at 4-30 $^ \circ C$ for 24 months.

d. Detection limit:

Not applicable.

e. Analytical specificity:

The potential effect of endogenous and exogenous interferents was tested by spiking the interferents into drug-free urine and target drug(s) urine with concentrations at $2 5 \%$ below and $2 5 \%$ above the cut-off levels. Compounds that showed no positive or negative interference at a concentration of $1 0 0 \mu \mathrm { g / m L }$ are summarized in the following tables. The substances tested and concentrations are shown below:

Buprenorphine and Methadone:

<table><tr><td rowspan=1 colspan=1>Acetophenetidin</td><td rowspan=1 colspan=1>Ethyl-p-aminobenzoate</td><td rowspan=1 colspan=1>Phencyclidine</td></tr><tr><td rowspan=1 colspan=1>N-Acetylprocainamide</td><td rowspan=1 colspan=1>Fenoprofen</td><td rowspan=1 colspan=1>Phenelzine</td></tr><tr><td rowspan=1 colspan=1>Acetylsalicylic Acid(Aspirin)</td><td rowspan=1 colspan=1>Furosemide</td><td rowspan=1 colspan=1>Phenobarbital</td></tr><tr><td rowspan=1 colspan=1>Aminopyrine</td><td rowspan=1 colspan=1>Gentisic acid</td><td rowspan=1 colspan=1>Phentermine</td></tr><tr><td rowspan=1 colspan=1>Amitriptyline</td><td rowspan=1 colspan=1>Hemoglobin</td><td rowspan=1 colspan=1>Phenylephrine-L</td></tr><tr><td rowspan=1 colspan=1>Amoxicillin</td><td rowspan=1 colspan=1>Hydralazine</td><td rowspan=1 colspan=1>Phenylethylamine</td></tr><tr><td rowspan=1 colspan=1>Amobarbital</td><td rowspan=1 colspan=1>(+/-)-4-HydroxyamphetamineHCL</td><td rowspan=1 colspan=1>Phenylpropanolamine</td></tr><tr><td rowspan=1 colspan=1>D-Amphetamine</td><td rowspan=1 colspan=1>Hydrochlorothiazide</td><td rowspan=1 colspan=1>Prednisolone Acetate</td></tr><tr><td rowspan=1 colspan=1>L-Amphetamine</td><td rowspan=1 colspan=1>Hydrocodone</td><td rowspan=1 colspan=1>Prednisone</td></tr><tr><td rowspan=1 colspan=1>Amphetamine Sulfate</td><td rowspan=1 colspan=1>Hydrocortisone</td><td rowspan=1 colspan=1>Procaine(Novocaine)</td></tr><tr><td rowspan=1 colspan=1>Ampicinine(Ampicillin)</td><td rowspan=1 colspan=1>Hydroxyhippuric acid</td><td rowspan=1 colspan=1>Promazine</td></tr><tr><td rowspan=1 colspan=1>Apomorphine</td><td rowspan=1 colspan=1>p-Hydroxymethamphetamine</td><td rowspan=1 colspan=1>Promethazine</td></tr></table>

\* Tested with Buprenorphine assay only   

<table><tr><td rowspan=1 colspan=1>L-Ascorbic Acid</td><td rowspan=1 colspan=1>Ibuprofen</td><td rowspan=1 colspan=1>Propoxyphene,d-</td></tr><tr><td rowspan=1 colspan=1>Aspartame</td><td rowspan=1 colspan=1>Imipramine</td><td rowspan=1 colspan=1>Propranolol</td></tr><tr><td rowspan=1 colspan=1>Atropine</td><td rowspan=1 colspan=1>Isoxsuprine</td><td rowspan=1 colspan=1>PseudoephedrineHCL</td></tr><tr><td rowspan=1 colspan=1>Benzilic acid</td><td rowspan=1 colspan=1>Isoproterenol-(+/-)</td><td rowspan=1 colspan=1>Quinidine</td></tr><tr><td rowspan=1 colspan=1>Benzphetamine</td><td rowspan=1 colspan=1>Ketamine</td><td rowspan=1 colspan=1>Quinine</td></tr><tr><td rowspan=1 colspan=1>Bezoic Acid</td><td rowspan=1 colspan=1>Labetalol</td><td rowspan=1 colspan=1>Ranitidine(Zantac)</td></tr><tr><td rowspan=1 colspan=1>Bilirubin</td><td rowspan=1 colspan=1>Levorphanol</td><td rowspan=1 colspan=1>Salicylic Acid</td></tr><tr><td rowspan=1 colspan=1>Caffeine</td><td rowspan=1 colspan=1>Loperamide</td><td rowspan=1 colspan=1>Secobarbital</td></tr><tr><td rowspan=1 colspan=1>Chloramphenicol</td><td rowspan=1 colspan=1>Maprotiline</td><td rowspan=1 colspan=1>Serotonin</td></tr><tr><td rowspan=1 colspan=1>Chlordiazepoxide HCL</td><td rowspan=1 colspan=1>Meprobamate</td><td rowspan=1 colspan=1>Sulfamethazine</td></tr><tr><td rowspan=1 colspan=1>Chloroquine</td><td rowspan=1 colspan=1>Methadone*</td><td rowspan=1 colspan=1>Sulindac</td></tr><tr><td rowspan=1 colspan=1>Chlorothiazide</td><td rowspan=1 colspan=1>Methoxyphenamine</td><td rowspan=1 colspan=1>Temazepam</td></tr><tr><td rowspan=1 colspan=1>Chlorpheniramine</td><td rowspan=1 colspan=1>(+/-)-Methylenedioxyamphetamine(MDA)</td><td rowspan=1 colspan=1>11-Nor-Δ9-Tetrahydrocannabinol</td></tr><tr><td rowspan=1 colspan=1>Chlorpromazine</td><td rowspan=1 colspan=1>Methylphenidate</td><td rowspan=1 colspan=1>Tetracycline</td></tr><tr><td rowspan=1 colspan=1>Cholesterol</td><td rowspan=1 colspan=1>Nalbuphine</td><td rowspan=1 colspan=1>Tetrahydrozoline</td></tr><tr><td rowspan=1 colspan=1>Clomipramine</td><td rowspan=1 colspan=1>Nalidixic acid</td><td rowspan=1 colspan=1>Thiamine</td></tr><tr><td rowspan=1 colspan=1>Clonidinehydrochloride</td><td rowspan=1 colspan=1>Naloxone hydrochloride</td><td rowspan=1 colspan=1>L-Thyroxine</td></tr><tr><td rowspan=1 colspan=1>Cortisone</td><td rowspan=1 colspan=1>Naltrexone hydrochloride</td><td rowspan=1 colspan=1>ThioridazineHydrochloride</td></tr><tr><td rowspan=1 colspan=1>Cotinine(-)</td><td rowspan=1 colspan=1>Naproxen</td><td rowspan=1 colspan=1>Triamterene</td></tr><tr><td rowspan=1 colspan=1>Creatinine</td><td rowspan=1 colspan=1>Niacinamide</td><td rowspan=1 colspan=1>TriflupromazineHydrochloride</td></tr><tr><td rowspan=1 colspan=1>Deoxyepinephrine</td><td rowspan=1 colspan=1>Nifedipine</td><td rowspan=1 colspan=1>Trimethoprim</td></tr><tr><td rowspan=1 colspan=1>Dextromethorphan</td><td rowspan=1 colspan=1>Norethindrone</td><td rowspan=1 colspan=1>Trimipramine</td></tr><tr><td rowspan=1 colspan=1>Diazepam</td><td rowspan=1 colspan=1>Norpropoxyphene</td><td rowspan=1 colspan=1>Tryptamine</td></tr><tr><td rowspan=1 colspan=1>Diflunisal</td><td rowspan=1 colspan=1>Noscapine</td><td rowspan=1 colspan=1>DL-Tryptophan</td></tr><tr><td rowspan=1 colspan=1>Digoxin</td><td rowspan=1 colspan=1>Oxazepam</td><td rowspan=1 colspan=1>Tyramine</td></tr><tr><td rowspan=1 colspan=1>Doxylamine</td><td rowspan=1 colspan=1>Oxymetazoline</td><td rowspan=1 colspan=1>D/L-Tyrosine</td></tr><tr><td rowspan=1 colspan=1>Ecgonine methylester</td><td rowspan=1 colspan=1>Papaverine</td><td rowspan=1 colspan=1>Uric Acid</td></tr><tr><td rowspan=1 colspan=1>R(-)-Epinephrine</td><td rowspan=1 colspan=1>Penicillin</td><td rowspan=1 colspan=1>Verapamil</td></tr><tr><td rowspan=1 colspan=1>Erythromycin</td><td rowspan=1 colspan=1>Pentobarbital</td><td rowspan=1 colspan=1>Zomepirac</td></tr><tr><td rowspan=1 colspan=1>Estrone-3-sulfate</td><td rowspan=1 colspan=1>Perphenazine</td><td rowspan=1 colspan=1></td></tr></table>

To test specificity, drug metabolites and other compounds structurally similar to methadone and buprenorphine were tested using three batches of each device. The lowest concentration that caused a positive result for each compound is listed below. There were no differences observed between the different formats. Results are summarized below:

<table><tr><td rowspan=1 colspan=1>Buprenorphine(Cut-off=10 ng/mL)</td><td rowspan=1 colspan=1>Result</td><td rowspan=1 colspan=1>%Cross-Reactivity</td></tr><tr><td rowspan=1 colspan=1>Buprenorphine</td><td rowspan=1 colspan=1>Positive at 10 ng/mL</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Buprenorphine -3-D-Glucuronide</td><td rowspan=1 colspan=1>Positive at 10 ng/mL</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Norbuprenorphine</td><td rowspan=1 colspan=1>Positive at 50 ng/mL</td><td rowspan=1 colspan=1>20%</td></tr><tr><td rowspan=1 colspan=1>Norbuprenorphine-3-D-Glucuronide</td><td rowspan=1 colspan=1>Positive at 100 ng/mL</td><td rowspan=1 colspan=1>10%</td></tr><tr><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>Negative at 100,000</td><td rowspan=1 colspan=1>&lt;0.01%</td></tr><tr><td rowspan=1 colspan=1>Oxymorphone</td><td rowspan=1 colspan=1>Negative at 100,000</td><td rowspan=1 colspan=1>&lt;0.01%</td></tr><tr><td rowspan=1 colspan=1>Hydromorphone</td><td rowspan=1 colspan=1>Negative at 100,000</td><td rowspan=1 colspan=1>&lt;0.01%</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Methadone(Cut-off=300 ng/mL)</td><td rowspan=1 colspan=1>Result</td><td rowspan=1 colspan=1>%Cross-Reactivity</td></tr><tr><td rowspan=1 colspan=1>Methadone</td><td rowspan=1 colspan=1>Positive at 300 ng/mL</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Doxylamine</td><td rowspan=1 colspan=1>Positive at 5000 ng/mL</td><td rowspan=1 colspan=1>6%</td></tr><tr><td rowspan=1 colspan=1>LAAM HCI</td><td rowspan=1 colspan=1>Positive at 10000 ng/mL</td><td rowspan=1 colspan=1>3%</td></tr><tr><td rowspan=1 colspan=1>Alpha Methadol</td><td rowspan=1 colspan=1>Positive at 2000 ng/mL</td><td rowspan=1 colspan=1>15%</td></tr><tr><td rowspan=1 colspan=1>EDDP</td><td rowspan=1 colspan=1>Negative at 100,000</td><td rowspan=1 colspan=1>&lt;0.3%</td></tr><tr><td rowspan=1 colspan=1>EMDP</td><td rowspan=1 colspan=1>Negative at 100,000</td><td rowspan=1 colspan=1>&lt;0.3%</td></tr></table>

To investigate the effect of urine specific gravity and urine $\mathsf { p H }$ , urine samples, with 1.000 to 1.035 specific gravity or urine samples with $\mathrm { p H } 4$ to 9 were spiked with target drugs at $2 5 \%$ below and $2 5 \%$ above the cutoff levels. These samples were tested using three lots of each device. Results were all positive for samples at and above $+ 2 5 \%$ cutoff and all negative for samples at and below $- 2 5 \%$ CutOff. There were no differences observed for different formats.

f. Assay cut-off:

Characterization of how the device performs analytically around the claimed cutoff concentration appears in the precision/reproducibility section above.

2. Comparison studies:

# a. Method comparison with predicate device:

Method comparison studies for the AssureTech Buprenorphine Tests and the AssureTech Methadone Tests were performed in-house with three laboratory assistants for each device. Operators ran 80 (40 negative and 40 positive)

unaltered clinical samples. The samples were compared to GC/MS results. The results are presented in the tables below:

Buprenorphine   

<table><tr><td rowspan=1 colspan=1>Strip</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byGC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Between thecutoff and+50%)</td><td rowspan=1 colspan=1>High Positiveby GC/MS(greater than+50%</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results of Buprenorphine Strip   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>StripViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>11178</td><td rowspan=1 colspan=1>9.8</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>20805</td><td rowspan=1 colspan=1>9.6</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>20805</td><td rowspan=1 colspan=1>9.6</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>20805</td><td rowspan=1 colspan=1>9.6</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>31718</td><td rowspan=1 colspan=1>10.9</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>18342</td><td rowspan=1 colspan=1>10.6</td><td rowspan=1 colspan=1>Negative</td></tr></table>

<table><tr><td rowspan=1 colspan=1>PanelDip</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byGC/MS(less than-50%</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Between thecutoff and+50%</td><td rowspan=1 colspan=1>High Positiveby GC/MS(greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results of Buprenorphine Panel Dip   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Panel DipViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>11178</td><td rowspan=1 colspan=1>9.8</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>20805</td><td rowspan=1 colspan=1>9.6</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>11178</td><td rowspan=1 colspan=1>9.8</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>20805</td><td rowspan=1 colspan=1>9.6</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>11178</td><td rowspan=1 colspan=1>9.8</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>20805</td><td rowspan=1 colspan=1>9.6</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>18342</td><td rowspan=1 colspan=1>10.6</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>31718</td><td rowspan=1 colspan=1>10.9</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>31718</td><td rowspan=1 colspan=1>10.9</td><td rowspan=1 colspan=1>Negative</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Turn-KeySplitCup</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byGC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Between thecutoff and+50%</td><td rowspan=1 colspan=1>High Positiveby GC/MS(greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results of Buprenorphine Turn-Key Split Cup   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Turn-Key SplitCup</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>20805</td><td rowspan=1 colspan=1>9.6</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>11178</td><td rowspan=1 colspan=1>9.8</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>11178</td><td rowspan=1 colspan=1>9.8</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>31718</td><td rowspan=1 colspan=1>10.9</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>18342</td><td rowspan=1 colspan=1>10.6</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>18342</td><td rowspan=1 colspan=1>10.6</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>31718</td><td rowspan=1 colspan=1>10.9</td><td rowspan=1 colspan=1>Negative</td></tr></table>

<table><tr><td rowspan=1 colspan=1>QuickCup</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byGC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Between thecutoff and+50%)</td><td rowspan=1 colspan=1>High Positiveby GC/MS(greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results of Buprenorphine Quick Cup   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Quick CupViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>20805</td><td rowspan=1 colspan=1>9.6</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>11178</td><td rowspan=1 colspan=1>9.8</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>11178</td><td rowspan=1 colspan=1>9.8</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>20805</td><td rowspan=1 colspan=1>9.6</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>31718</td><td rowspan=1 colspan=1>10.9</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>18342</td><td rowspan=1 colspan=1>10.6</td><td rowspan=1 colspan=1>Negative</td></tr></table>

# Methadone (MTD)

<table><tr><td rowspan=1 colspan=1>Strip</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byGC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Between thecutoff and+50%</td><td rowspan=1 colspan=1>High Positiveby GC/MS(greater than+50%</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results of MTD Strip   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>StripViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>36406</td><td rowspan=1 colspan=1>293</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>15168</td><td rowspan=1 colspan=1>291</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>15168</td><td rowspan=1 colspan=1>291</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>15168</td><td rowspan=1 colspan=1>291</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>82949</td><td rowspan=1 colspan=1>305</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>82949</td><td rowspan=1 colspan=1>305</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>82949</td><td rowspan=1 colspan=1>305</td><td rowspan=1 colspan=1>Negative</td></tr></table>

<table><tr><td rowspan=1 colspan=1>PanelDip</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byGC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Between thecutoff and+50%)</td><td rowspan=1 colspan=1>High Positiveby GC/MS(greater than+50%</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results of MTD Panel Dip   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Panel DipViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>36406</td><td rowspan=1 colspan=1>293</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>15168</td><td rowspan=1 colspan=1>291</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>15168</td><td rowspan=1 colspan=1>291</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>15168</td><td rowspan=1 colspan=1>291</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>82949</td><td rowspan=1 colspan=1>305</td><td rowspan=1 colspan=1>Negative</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Turn-KeySplitCup</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byGC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Between thecutoff and+50%</td><td rowspan=1 colspan=1>High Positiveby GC/MS(greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results of MTD Turn-Key Split Cup   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Split CupViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>15168</td><td rowspan=1 colspan=1>291</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>15168</td><td rowspan=1 colspan=1>291</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>36406</td><td rowspan=1 colspan=1>293</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>82949</td><td rowspan=1 colspan=1>305</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>82949</td><td rowspan=1 colspan=1>305</td><td rowspan=1 colspan=1>Negative</td></tr></table>

<table><tr><td rowspan=1 colspan=1>QuickCup</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byGC/MS(less than-50%</td><td rowspan=1 colspan=1>Near CutoffNegative byGC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byGC/MS(Between thecutoff and+50%)</td><td rowspan=1 colspan=1>High Positiveby GC/MS(greater than+50%</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>14</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>25</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results of MTD Quick Cup   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>GC/MS Result</td><td rowspan=1 colspan=1>Quick CupViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>36406</td><td rowspan=1 colspan=1>293</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>36406</td><td rowspan=1 colspan=1>293</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>15168</td><td rowspan=1 colspan=1>291</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>36406</td><td rowspan=1 colspan=1>293</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>82949</td><td rowspan=1 colspan=1>305</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>82949</td><td rowspan=1 colspan=1>305</td><td rowspan=1 colspan=1>Negative</td></tr></table>

Lay-user study:

A lay user study was performed at three intended user sites with 273 study subjects for 3 formats and 147 study subjects for 2 formats. The lay users had diverse educational and professional backgrounds and ranged in age from 18 to ${ > } 5 0$ years. Urine samples were prepared at the following concentrations; negative, $+ / - 7 5 \% , + / - 5 0 \% , + / - 2 5 \%$ of the cutoff by spiking drug(s) into drug free-pooled urine specimens. The concentrations of the samples were confirmed by GC/MS. Each sample was aliquotted into individual containers and blind-labeled. Each participant was provided with the package insert, 1 blind labeled sample and a device. Each device format was tested.

Comparison between GC/MS and Lay Person Results for Buprenorphine Strip:   

<table><tr><td colspan="1" rowspan="2">% of Cutoff</td><td colspan="1" rowspan="2">Numberofsamples</td><td colspan="1" rowspan="2">BuprenorphineConcentration by GC/MS(ng/mL)</td><td colspan="2" rowspan="1">Lay person results</td><td colspan="1" rowspan="2">The percentageof correctresults (%)</td></tr><tr><td colspan="1" rowspan="1">No. ofPositive</td><td colspan="1" rowspan="1">No. ofNegative</td></tr><tr><td colspan="1" rowspan="1">-100%Cutoff</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-75%Cutoff</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">2.2</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50% Cutoff</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">5.5</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25%Cutoff</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">7.6</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+25%Cutoff</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">12.6</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+50% Cutoff</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">16.2</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+75% Cutoff</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">17.8</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="2">% of Cutoff</td><td colspan="1" rowspan="2">Number ofsample</td><td colspan="1" rowspan="2">MethadoneConcentration byGC/MS (ng/mL)</td><td colspan="2" rowspan="1">Lay person results</td><td colspan="1" rowspan="2">The percentageof correctresults (%)</td></tr><tr><td colspan="1" rowspan="1">No. ofPositive</td><td colspan="1" rowspan="1">No. ofNegative</td></tr><tr><td colspan="1" rowspan="1">-100%Cutoff</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-75%Cutoff</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">69</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50% Cutoff</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">162</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25% Cutoff</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">251</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+25% Cutoff</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">389</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+50% Cutoff</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">463</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+75% Cutoff</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">510</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr></table>

Comparison between GC/MS and Lay Person Results for BUP/MTD Panel DipCard   

<table><tr><td rowspan=2 colspan=1>% Cutoff</td><td rowspan=2 colspan=1>No ofsamples</td><td rowspan=1 colspan=2>Concentration byGC/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person results</td><td rowspan=1 colspan=2>Correct Results(%)</td></tr><tr><td rowspan=1 colspan=1>Buprenorphine</td><td rowspan=1 colspan=1>Methadone</td><td rowspan=1 colspan=1>BUP</td><td rowspan=1 colspan=1>MTD</td><td rowspan=1 colspan=1>BUP</td><td rowspan=1 colspan=1>MTD</td></tr><tr><td rowspan=1 colspan=1>-100%</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0+/21-</td><td rowspan=1 colspan=1>0+/21-</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>2.2</td><td rowspan=1 colspan=1>69</td><td rowspan=1 colspan=1>0+/21-</td><td rowspan=1 colspan=1>0+/21-</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>5.5</td><td rowspan=1 colspan=1>162</td><td rowspan=1 colspan=1>0+/21-</td><td rowspan=1 colspan=1>0+/21-</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>7.6</td><td rowspan=1 colspan=1>251</td><td rowspan=1 colspan=1>1+/20-</td><td rowspan=1 colspan=1>2+/19-</td><td rowspan=1 colspan=1>95</td><td rowspan=1 colspan=1>90</td></tr><tr><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>12.6</td><td rowspan=1 colspan=1>389</td><td rowspan=1 colspan=1>20+/1-</td><td rowspan=1 colspan=1>20+/1-</td><td rowspan=1 colspan=1>95</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>16.2</td><td rowspan=1 colspan=1>463</td><td rowspan=1 colspan=1>21+/0-</td><td rowspan=1 colspan=1>21+/0-</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>17.8</td><td rowspan=1 colspan=1>510</td><td rowspan=1 colspan=1>21+/0-</td><td rowspan=1 colspan=1>21+/0-</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>100</td></tr></table>

Comparison between GC/MS and Lay Person Results for BUP/MTD Turn-Key Split Cup   

<table><tr><td colspan="1" rowspan="2">% Cutoff</td><td colspan="1" rowspan="2">No ofsamples</td><td colspan="2" rowspan="1">Concentration byGC/MS(ng/mL)</td><td colspan="2" rowspan="1">Lay person results</td><td colspan="2" rowspan="1">Correct Results(%)</td></tr><tr><td colspan="1" rowspan="1">Buprenorphine</td><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">BUP</td><td colspan="1" rowspan="1">MTD</td><td colspan="1" rowspan="1">BUP</td><td colspan="1" rowspan="1">MTD</td></tr><tr><td colspan="1" rowspan="1">-100%</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0+/21-</td><td colspan="1" rowspan="1">0+/21-</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-75%</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">2.2</td><td colspan="1" rowspan="1">69</td><td colspan="1" rowspan="1">0+/21-</td><td colspan="1" rowspan="1">0+/21-</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50%</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">5.5</td><td colspan="1" rowspan="1">162</td><td colspan="1" rowspan="1">0+/21-</td><td colspan="1" rowspan="1">0+/21-</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25%</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">7.6</td><td colspan="1" rowspan="1">251</td><td colspan="1" rowspan="1">2+/19-</td><td colspan="1" rowspan="1">0+/21-</td><td colspan="1" rowspan="1">90</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+25%</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">12.6</td><td colspan="1" rowspan="1">389</td><td colspan="1" rowspan="1">20+/1-</td><td colspan="1" rowspan="1">20+/1-</td><td colspan="1" rowspan="1">95</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+50%</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">16.2</td><td colspan="1" rowspan="1">463</td><td colspan="1" rowspan="1">21+/0-</td><td colspan="1" rowspan="1">21+/0-</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+75%</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">17.8</td><td colspan="1" rowspan="1">510</td><td colspan="1" rowspan="1">21+/0-</td><td colspan="1" rowspan="1">21+/0-</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25%</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">7.6</td><td colspan="1" rowspan="1">251</td><td colspan="1" rowspan="1">0+/21-</td><td colspan="1" rowspan="1">1+/20-</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+25%</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">12.6</td><td colspan="1" rowspan="1">389</td><td colspan="1" rowspan="1">20+/1-</td><td colspan="1" rowspan="1">21+/0-</td><td colspan="1" rowspan="1">95</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+50%</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">16.2</td><td colspan="1" rowspan="1">463</td><td colspan="1" rowspan="1">21+/0-</td><td colspan="1" rowspan="1">21+/0-</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+75%</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">17.8</td><td colspan="1" rowspan="1">510</td><td colspan="1" rowspan="1">21+/0-</td><td colspan="1" rowspan="1">21+/0-</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">100</td></tr></table>

Lay-users were also given surveys on the ease of understanding the package insert instructions. All lay users indicated that the device instructions can be easily followed. A Flesch-Kincaid reading analysis was performed on each package insert and the scores revealed a reading Grade Level of 7.

b. Matrix comparison: Not applicable

3. Clinical studies:

a. Clinical Sensitivity: Not applicable

b. Clinical specificity: Not applicable   
c. Other clinical supportive data (when a. and b. are not applicable): Not applicable

4. Clinical cut-off: Not applicable

5. Expected values/Reference range: Not applicable

# N. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.